| RS1845126730 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS184512808 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1845135533 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845135625 |
TSC1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1845139251 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS1845145732 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS1845148693 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1845149321 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845156018 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS1845169599 |
PAX2
|
Health Risk |
Pathogenic |
Renal coloboma syndrome, Focal segmental glomerulosclerosis 7 |
| RS184516994 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS184519036 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
TJP2-related disorder, TJP2-related disorder |
| RS1845193663 |
HPS1
|
Health Risk |
Likely pathogenic |
— |
| RS184521520 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS184522376 |
GPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Transient infantile hypertriglyceridemia and hepatosteatosis, Transient infantile hypertriglyceridemia and hepatosteatosis |
| RS184523779 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS184524479 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS1845317249 |
HPS1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome 1 |
| RS1845327789 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845328711 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845364215 |
PAX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal coloboma syndrome, Focal segmental glomerulosclerosis 7 |
| RS1845366198 |
PAX2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 7, Renal coloboma syndrome |
| RS184537159 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS1845380748 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1845383523 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Blepharophimosis - intellectual disability syndrome |
| RS1845409168 |
PAX2
|
Health Risk |
Likely pathogenic |
— |
| RS1845410479 |
PAX2
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 7, Focal segmental glomerulosclerosis 7 |
| RS1845411121 |
PAX2
|
Health Risk |
Likely pathogenic |
Steroid-resistant nephrotic syndrome, Focal segmental glomerulosclerosis |
| RS184541137 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1845412705 |
PAX2
|
Health Risk |
Pathogenic |
Renal coloboma syndrome, Focal segmental glomerulosclerosis 7 |
| RS1845429019 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS1845433207 |
KAT6B
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS1845446236 |
TSC1
|
Health Risk |
Pathogenic |
Lymphangiomyomatosis, Lymphangiomyomatosis |
| RS1845452711 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845453970 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS184545855 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Inflammatory bowel disease 1 |
| RS1845495899 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1845497321 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845500156 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia, Citrullinemia |
| RS1845500801 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845504382 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845506282 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS1845507027 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia, Citrullinemia type I |
| RS1845510486 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1845511359 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1845534948 |
HPS1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS1845544924 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1845545201 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1845545378 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1845545985 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1845547583 |
CNNM2
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS1845548849 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1845549017 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Tuberous sclerosis syndrome |
| RS1845550578 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, Hypomagnesemia |
| RS1845553116 |
CNNM2
|
Health Risk |
Pathogenic |
Hypomagnesemia, seizures |
| RS1845559552 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS184556570 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS184559206 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1845604585 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845607838 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS184561385 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1845615656 |
TSC1
|
Health Risk |
Pathogenic |
Lymphangiomyomatosis, Lymphangiomyomatosis |
| RS1845617102 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845635382 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, TSC1-related disorder |
| RS184563685 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory and autonomic |
| RS1845637294 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1845641716 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845643067 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845652182 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845652716 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845654716 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS184567726 |
TYK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 35, Immunodeficiency 35 |
| RS1845700817 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS184570956 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia, autosomal recessive |
| RS1845711244 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS1845712748 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS184572250 |
RNASET2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic leukoencephalopathy without megalencephaly, Cystic leukoencephalopathy without megalencephaly |
| RS1845724649 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845728736 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1845730108 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS184573698 |
F7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital factor VII deficiency, Congenital factor VII deficiency |
| RS1845754405 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia, Papillary renal cell carcinoma type 1 |
| RS184575465 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1845756775 |
PNPLA2
|
Health Risk |
Pathogenic |
— |
| RS1845759700 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1845790373 |
SLC29A3
|
Health Risk |
Likely pathogenic |
H syndrome, H syndrome |
| RS1845791308 |
CTSD
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1845792332 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1845839718 |
INS
|
Health Risk |
Likely risk allele |
Diabetes mellitus, Type 1 diabetes mellitus 2 |
| RS1845841728 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1845848773 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Multisystemic smooth muscle dysfunction syndrome, Aortic aneurysm |
| RS1845849420 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 10, Neuronal ceroid lipofuscinosis |
| RS1845849997 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 10, Neuronal ceroid lipofuscinosis |
| RS1845850847 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS184585202 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS184586428 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Van Maldergem syndrome 1, DCHS1-related disorder |
| RS184587113 |
ETFA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Glutaric acidemia type 2A |
| RS1845873878 |
INS;INS-IGF2
|
Health Risk |
Likely pathogenic |
Diabetes mellitus, Neonatal insulin-dependent diabetes mellitus |
| RS184587533 |
LIPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipidemia due to hepatic triglyceride lipase deficiency, Type 2 diabetes mellitus |
| RS1845876806 |
SLC29A3
|
Health Risk |
Likely pathogenic |
H syndrome, H syndrome |